liquidia.com (LQDA): Net earnings per share growth forecast for next year

Liquidia Corporation (LQDA) - corporate logo

The ESG strategy and therapy quality control of Liquidia Corporation (LQDA) are reflected in profit dynamics; analyzing the EPS forecast trend on GURU.Markets, we see that the 3178.30 mark serves as the current indicator. Patent protection for drug delivery methods curbs competition, while technological partnerships for inhalation delivery replace M&A activity amid ongoing litigation.

Liquidia Corp (LQDA): Net earnings per share growth forecast for next year from 07/04/2022 to 11/17/2026

Summary analytical data breakdowns for Liquidia Technologies (LQDA)

- share price and consensus valuation forecast:
Basic company analysis:liquidia.com, LQDA
Core merchandise of Liquidia Corp

This indicator reflects the consensus forecast for earnings per share growth next year, allowing investors to assess the fundamental growth potential and the risk of asset valuation revisions. By analyzing the forward EPS dynamics model for Liquidia Corporation (LQDA), market expectations can be linked to the commercialization of patented inhalation therapy systems, confirming the long-term sustainability of the biopharmaceutical business.

Competitor analysis

Net earnings per share growth forecast for next year Haleon plc|Expected net earnings per share growth next year kenvue.com KVUE|Net earnings per share growth forecast for next year Verona Pharma (VRNA)|MENS (Jyong Biotech Limited) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Ligand Pharma LGND|Earnings growth forecast for next year Amneal Corp AMRX|Perrigo Company PLC - Earnings growth forecast for next year|ALVO: Net earnings per share growth forecast for next year|Galapagos (GLPG) - Net earnings per share growth forecast for next year|ANIP - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year MannKind Corporation|AMPH: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Pacira BioSciences (PCRX)|SPRY: Net earnings per share change forecast for next year|Theravance Biopharma, Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year AQST (Aquestive Therapeutics, Inc.)|SCPH - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year tectonictx.com TECX|TNXP: Earnings growth forecast for next year|Projected earnings per share growth rate for next year SXTC|Expected earnings per share growth for next year EPRX|BioHarvest (BHST) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year EXOZ|Earnings growth forecast for next year Oramed (ORMP)|Entera Bio Ltd. - Expected earnings per share growth for next year|ipatherapeutics.com (HYFT) - Expected net earnings per share growth next year|ABVC - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year CPIX|QNTM: Earnings growth forecast for next year|FGEN - Consensus forecast of earnings per share growth for next year|TELO (Telomir Pharmaceuticals Corp) - Earnings growth forecast for next year|RANI (Rani Therapeutics) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Synergy CHC Corp. (SNYR)|RLYB (Rallybio) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year lexariabioscience.com LEXX|Earnings growth forecast for next year Pulmatrix Corporation PULM|PTHL - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Aptorum Group Ltd APM|LYRA (Lyra Therapeutics) - Expected earnings per share growth for next year|IBO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year TNF Pharmaceuticals, Inc.|Expected earnings per share growth for next year cbdMD, Inc. (YCBD)|Net earnings per share growth forecast for next year PainReform Limited (PRFX)|Expected earnings per share growth for next year Altamira Therapeutics Ltd CYTO|Earnings growth forecast for next year LIPO (lipella.com)|Expected earnings per share trend next year OPTN|PIRS - Net earnings per share growth forecast for next year|Procaps Group Corp (PROC) - Expected earnings per share growth for next year|Petros (PTPI) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year QLI (Qilian International)|Expected earnings per share growth for next year SLRN|TFF Pharmaceuticals, Inc. - Net earnings per share change forecast for next year